Market Access Archives

helps to optimise the value of innovation

Separate or hybrid economic models?

Added on 09/04/2025

Managing Uncertainty via Deterministic Sensitivity Analysis

Added on 29/03/2025

Incidence versus prevalence in economic studies

Added on 02/03/2025

AI in Healthcare: Risks and Opportunities

Added on 16/03/2024

The value of a proven pricing structure

Added on 30/01/2024

How to prove the concerned price if the specialty is not yet produced? What is the value of a proven pricing structure if the price is downsized over time? Lets discuss to overcome this bottleneck.

Model hygiëne

Added on 27/10/2023

You dive into a simulation model and at first everything seems flawless. But with each adjustment the risk of flaws creeping into the programming.

Willingness to Pay (WTP) versus Medical Need

Added on 28/07/2023

The 'ICER' is a well-known measure to assess the extra cost to invest to win one QALY. In Belgium, unofficially 35 000 € / QALY gained is often applied as benchmark, the 'willingness to pay' (WTP). But does the payer invest the budget in function of the potential medical need or not ?

Cost Minimisation Model

Added on 28/04/2023

How to prove the ‘added value’ when the concerned innovation is beneficial without producing ‘health’ in a direct way?

The value of ‘Net Monetary Benefit’

Added on 27/10/2022

How to indicate if an innovation is worthwhile to pay for in view of the claimed benefit it will bring? The goal of the NMB is to compare two interventions by subtracting the NMB of ‘intervention A’ from the NMB of ‘intervention B’, resulting in the incremental NMB (iNMB).

Health state transition models

Added on 01/07/2022

Always wondered how health economic models work? Good news: this blog is developed to guide you through the basic elements of ‘health state transition models’.